Detalhe da pesquisa
1.
Predictive value of 1q21 gain in multiple myeloma is strongly dependent on concurrent cytogenetic abnormalities and first-line treatment.
Am J Cancer Res
; 11(9): 4438-4454, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34659897